Effect of Once‐Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial

BACKGROUND: In the EXSCEL (Exenatide Study of Cardiovascular Event Lowering), exenatide once‐weekly resulted in a nonsignificant reduction in major adverse cardiovascular events (MACEs) and a nominal 14% reduction in all‐cause mortality in 14 752 patients with type 2 diabetes mellitus (T2DM) with an...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Am Heart Assoc
Main Authors: Mentz, Robert J., Bethel, M. Angelyn, Merrill, Peter, Lokhnygina, Yuliya, Buse, John B., Chan, Juliana C., Felício, João S., Goodman, Shaun G., Choi, Jasmine, Gustavson, Stephanie M., Iqbal, Nayyar, Lopes, Renato D., Maggioni, Aldo P., Öhman, Peter, Pagidipati, Neha J., Poulter, Neil R., Ramachandran, Ambady, Reicher, Barry, Holman, Rury R., Hernandez, Adrian F.
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2018
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6404902/
https://ncbi.nlm.nih.gov/pubmed/30371301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.009304
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker